FNEL

⚡ Flash Summary

First National Equities Limited (FNEL) reported a loss after tax of PKR 78.68 million for the year ended June 30, 2025, a significant decrease from the profit of PKR 497.90 million in 2019. Gross revenue decreased substantially to PKR 19.75 million compared to PKR 23.48 million in 2024 and PKR 6.75 million in 2019. The company’s operations were temporarily affected by transitioning its license framework, which involved a trading closure in September 2024 and a resumption in June 2025. Despite the losses, FNEL is pursuing strategic growth opportunities, including investments in its subsidiary and diversification into the pharmaceutical sector.

📌 Key Takeaways

• 📉 FNEL reported a loss after tax of PKR 78.68 million in 2025, a sharp reversal from a profit of PKR 497.90 million in 2019.
• 📉 Gross revenue significantly decreased to PKR 19.75 million in 2025 from PKR 23.48 million in 2024.
• ⚠️ Operating revenues decreased to PKR 8.56 million in 2025 from PKR 33.92 million in 2024.
• ⛔️ Administrative expenses remained high at PKR 41.77 million despite reduced revenue.
• 🏦 The company is transitioning its license framework, causing a trading halt in September 2024.
• ✅ Operations resumed in June 2025 under a trading-only broker status.
• 💰 FNEL is pursuing strategic growth opportunities, including investments in its subsidiary FNE Developments.
• 💊 The company intends to diversify into the pharmaceutical sector, potentially investing up to PKR 500 million.
• 🏢 The KSE-100 Index closed June 2025 at a historic high, but FNEL experienced volatility.
• 💼 The company divested its 20% equity stake in Kingbhai Digisol for PKR 280 million.
• 🚫 Auditors highlight non-compliance with corporate governance regulations, including vacant key positions.
• Chairman mentions FY2026 GDP growth of 3.6%, an improvement compared to -0.4% the year before

🎯 Investment Thesis

Based on the current financial performance and highlighted risks, a SELL recommendation is appropriate for FNEL. The company faces significant challenges related to the temporary operations closure. A turnaround is uncertain, and the lack of profitability makes investment unattractive. Even though the divestiture from Digisol could eventually have a positive impact, the investment comes with a high amount of uncertainty in the near term. The risks associated with the regulatory compliance and operational efficiency remain significant

⚡ Flash Summary

First National Equities Limited (FNEL) reported losses for the year ended June 30, 2025, with a loss after tax of Rs. 78.68 million compared to a loss of Rs. 51.47 million in the previous year. Operating revenue significantly decreased to Rs. 8.56 million from Rs. 33.92 million, influenced by a temporary trading closure and market volatility. The company is strategically pivoting towards new investments and pharmaceutical diversification to broaden its revenue base. Despite the losses, FNEL highlights its compliance with corporate governance standards and future growth prospects through strategic initiatives.

📌 Key Takeaways

• 📉 Loss after tax increased to Rs. 78.68 million in 2025 from Rs. 51.47 million in 2024.
• Revenue plummeted to Rs. 8.56 million from Rs. 33.92 million YoY. 📉
• Sale of investment resulted in gain of Rs.6.31 million compared to loss of Rs.6.05 million YoY. 💰
• Unrealized gain on investments saw an increase of Rs.4.88 million compared to loss of Rs.4.38 million YoY.📈
• Administrative expenses are down to Rs. 41.77 million compared to Rs. 76.83 million YoY. ✅
• Finance costs increased slightly to Rs. 25.30 million from Rs. 24.06 million. ⬆️
• Other income decreased to Rs. 35.37 million compared to Rs. 42.37 million YoY. 🔻
• KSE-100 Index closed June 2025 at 125,000 points, a 60% increase for FY25. 🚀
• Remittances reached a record US$38 billion in FY25, a 27% increase YoY. 💸
• The Company is exploring investment opportunities in its subsidiary, FNE Developments. 🏢
• Intends to diversify into the pharmaceutical sector with up to PKR 500 million in investments. 💊
• The company divested its 20% equity stake in Kingbhai Digisol for PKR 280 Million. 🤝
• Auditors have identified non-compliance issues including lack of Director Training. ⚠️
• Remuneration to Directors is provided according to policy guidelines. 💼

🎯 Investment Thesis

Given financial performance and risk factors, I recommend a SELL signal. The company is not profitable and has a variety of challenges to address. The company has non-compliance issues that must be resolved. I believe the price will continue to decline and I suggest a time horizon of medium term.